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by echocardiogrephy and the time constant of LV relaxation (Tau) was derived 
from the LV pressure to assess diastolic function in 94 consecutive patients 
with suspected cardiac disease. The sensitivity and specificity of optimal 
values of each papttde !or detecting abe l  LV function or LVH were: 
EF < 45% sensitiv~: BNP (83%) > C-ANP (79%) > N-ANP (67%) 
specific~y: BNP (81%) > C-ANP (67%) > N-ANP (63%) 
Tau > 55 ms sensitivity; BNP (85%) > N-ANP (70%) > C-ANP (60%) 
specificity: BNP t74%) :- C-ANP (65%) > N-ANP {81%) 
LV mass index > 120 g/m 2 sensitivity: BNP (81%) > N-ANP (73%) > C-ANP (69%) 
specificity: BNP (90%) :. N-ANP (79=/.) > C-ANP (67%) 
By recaiver-operator-charactadstic (ROC) analysis, BNP was significantly 
more sensitive and specific than C-ANP or N.ANP for dstecting abnormal 
ER Tau or LV mass index with an ROC value of 0.85, 0.8?,, and 0.91 respac- 
tive~y. Sensitivity for detecting abnormal LV structure or function employing 
a "natfluretic peptido penal ~ with an abnormal ~NP orC-ANP or N-ANP ax- 
ceeded that of BNP alone and was for EF < 4S% (96%), Tau < 55 ms (90%) 
and LV mass index > 120 g/m 2 (06%). Conclusions:BNP is the single best 
test to detect abnormal systolic and diastolic function and LVH in patients 
with suspected cardiac disease. A "natriuretic peptide panel" has very high 
sensitivity and may be a useful screening test in some populations. 
4:15 
~ Attenuation B.type Peptt=de (BNP) of Natrluretic 
Secreted From an Infarcted Segment Remssnts the 
Process of  Left Vantricular Remodeling After 
Myocardial Infarction 
Atsusht Hirayama, Fuminobu lshikura, Neeyu~ Misaki, Hisakasu Fuji, 
Takayoshi Adechi, Yashuhlko Seksta, Kazuhisa Kodama, Osaka Police 
Hospital, Osaka, Japan 
As B-type natduratic peptide (BNP) is known tO be a marker for ventdcu- 
lar hypertrophy and/or dilatation, its measurement at the infarcted segment 
might be useful to evaluate infarct expansion after the onset of myocardial 
infarction (M1). Seventy five patients of first antedor MI without any car- 
diac event since their first attack were subjected to cardiac catheterization 
performed 18 ± 15 months (range 1 to 45 months) after the onset of MI. 
Hemodynamic parameters, left ventdcular (LV) volumes and function on LV 
graphy and plasma BNP concentration (pg/ml) of aortic root (Ao) and anterior 
intervantdcular vein (AIV) were measured by radioimmuncessay. The differ- 
once of plasma BNP concentration between AIV and Aa {AIV-Ao), which 
reflect BNP secreted from the infarct segment, had significant correlations 
with EDVI (r = 0.67, p = 0.001), ESVI (r = 0,65, p = 0.001), EF (r = 0.71, p = 
0.001), LVEDP (r = 0.53, p = 0.003), and the duration from the onset of MI to 
the cardiac catheterization (r= -0.75, p = 0.001). By multivariate analysis, 
however, EDVI (p = 0.003) and the duration from the onset of MI (p = 0.0021 )
among the variables were picked up as significant factors determining the 
plasma concentration of BNP at AIV-Ao. These results indicated that BNP 
released from the infarcted segment is enhanced by the ventdcular dilatation 
and attenuated in the course of time after ML These results suggested the 
secretion of BNP at the infarcted segment w~c stimulated by the infarct ex- 
pansion at the eady pedod after MI but decrJased with the accomplishment 
of expansion dudng the late period. 
In conclusion, BNP secreted from the infarct segment represent he pro* 
cess of LV remodeling after MI. 
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1723-3 ~ Repetitive Bolus Administration of Brain Natriuratlc 
Peptlde Reduces Cardiac Filling Pressures in 
Human Heart Failure 
Robert J, Cody, for the Natrecor hBNP Multicenter Bolus Trial. Ohio State 
University, Columbus, Ohio 
Endogenous natduretic poptides (NP) produce vesodilallon, in response to 
the myocardial remodeling of congestive heart failure (CHF). individual NP 
sequences of single gone origin, confer distinct cardiovascular character- 
istics. In this multicenter trial, we evaluated the effect of repetitive bolus 
administration of brain nstriuretic peptide (hBNP) in patients (pts) with CHF, 
during hemodynamic evaluation. 28 of 29 pts were NYHA II1 or IV, and all 
had EF < 30%. hBNP was given as 5 #g Q4H (7 pts), 10 p.g Q4H (6 
pts), 10 #g Q6H (6 pts), with placebo groups for Q4H (6 tots) and QaH 
(4 pts) tnten/ais. For each treatment inten~i, pts received repetitive doses 
over 24 hrs. Placebo groups were pooled for statistical analysis, considering 
betwaen4wlthin-group differences, and dosage hierarchy, p < 0.05(') being 
significant. Pulmonary wedge (PWP) and dght atrial (RAP) pressures: 
PWp (mmH9) 
Baseline 
hBNP + 0.5 hrs 
hBNP + 1 hr8 
hBNP + 2 hm 
RAP (mmHg) 
Basins 
hBNP + 0,S hrS 
hBNP + 1 hrs 
hBNP ÷ 2 hrs 
Placebo 5EgQ4H ............. !0/~g,Q4H 10/~g Q6 H 
27=7 2S±6 ~±6 27~5 
26:~9 ta~:P 19:1:8 • 12:EP 
27±8 1S±6* 20~7" 13:~6" 
26:b5 18±8' 21 ~-9 ~ 16 d:6" 
15-;-8 13±8 12~4 12-1-7 
15±7 10~8" 84-p 7:~5" 
16±7 9±9" 8±6 '~ 6±5" 
14d:a 10~8" 7 -;- 4'* 7:~5- 
At the common time point of 12 hours, PWP (15 4. 5) and RAP (4 :t: 
5,) were p < 0,05 for the 10 #g Q4H interval, With the final bolus In each 
group, persistent response of PWP and RAP indicated no tachyphylaxis. 
Changes in cardiac index and system~ resistance were concordant, canals. 
tent with vasedilation. In human CHF, exogenous hBNP improves cardiac 
filling pressures in the setting of vasodilation, sugge -3ting preserved hamody- 
namic responsiveness of the "type A" NP re,~ptor, wl~tle reducing the atdai 
tension stimulus for endogenous NP release. 
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Exhaled Nitric Oxide as a Measure of Response to 
Therapy in Patients With Heart Failure 
Joshua M. Hare, Anthony R Massaro, Jeffrey M, Drezen, Wilson S. Colucoi. 
Bn'gham and Women's Hospital, Boston, MA 
Endogenous nitric oxide (NO) can be detected in exhaled air and increases 
with exercise and L-arginine administration, possibly reflecting vascular e- 
lease, We hypothesized that exhaled NO would be elevated in patients with 
heart failure (HF) as a compensatory cimulatory mechanism, and would de. 
crease as hemodynamtcs improved with vasedilator and diuretic therapy. 
Chemilumineeanca was used to measure mean mixed expil~l NO content 
of a vital capacity breath in patients with HF (n = 5) and matched controls (n 
= 5) dudng inhalation of NO-free air. Exhaled NO was higher in HF than in 
controls (8.4 :E 3.5 vs. 6.5 :t: 2.4 ppb, p < 0,04). Serial measurements were 
made over of period of therapy (7,3 4- 6 dayS) with sodium nitroprusstde 
(SNP) and diuresis dudng monitoring of pulmonary artedal pressures and 
cardlec output in 7 additional patients with HF breathing room air. 
Pro-therapy SNP for 2 hrs .  Post-therapy 
NO (ppb) 20.4 ~: 6.2 22.8 :b 4.6 11.2 "~ 1.2' 
PVR (dyne-sec-cm-5) 356 ~- 47 287 ± 63 147 ~ 32" 
co (U~n) 3 ~: 0.3 4.64 =~ 0.9 4.8 ± 0.3t" 
PCWP (mmHg) 31 ~: 3 27 :E 2 21 :E 71" 
*p < 0,05 vs. baseline and SNP, tp < 0.01 vs. baseline 
HF therapy improves hemedynamics and is as,~oclated with reductions 
in exhaled NO concentrations. Thus, elevations in exhaled NO may reflect 
a compensatory cimulatory mechanism in HI=, and exhaled NO may be an 
easily obtainable and quantifiable measure of clinical response to therapy in 
HR 
5:00 
~ Medulatlon of Tumor Necrosis Factor o~ in 
Advanced Heart Failure With Cachexla Is 
Associated Wilh Anabol lc Effects 
Richard V. Mtisni, Stefan Endres, Mandeep R, Mehra, Julia Cook, 
Andreas Eigler0 Frank W. Smart, Cad J. Lavla, Joseph R Murgo, Hector 
O. Vanfura. Ochsner Clinic, New Orleans. LA 
Tumor Necrosis Factor (TNF~) has catabolic effects which produce cachexia 
in laboratory animals and humans. Indeed, patients with advanced heart 
failure (aHF) who demonstrate elevated levels of TNFc< often suffer from 
cachexla, a finding characterized by reduced body ~'at. The purpose of this 
double blind, randomized, placebo-controlled study was to evaluate the im- 
pact of modulation of TNF= synthesis on alterations in body fat Indlces 
using n-3 fatty acids. 14 patients with aHF were randomly allocated to ac- 
tive treatment (n.3 fatty adds, 6.4 gins/d; n = 7) vs. t~ocaloric placebo (n 
= 7). TNF= production at baseline and after 18 weeks was assessed using 
lipopolysaccadde monocyte stimulation. 
t.TNF~ synthesis 4% Body Fat 
n-3 Fatty Acids -59% +9.5% 
Placebo +44% -4.2=/=, 
Regression analysis revealed that &TNF~ was inversely and significantly 
correlated with z~% body fat (r value = 0.60, p = 0.02). Conclusions: 1) 
N-3 fatty acid supplementation in aHF results in significant reductions in 
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TNF= synthesis which is associated with anabolic effects characterized by 
an increase in body fat, 2) These observations provide the first evidence of 
a clinically beneficial influence of modulation of TNF~ in aHF. 
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~ Reiea,ae o f  Adrenomedul l ln From the Human Fall i .g 
Ventricle 
Michthisa Jot~sakt, Richard J. Rodeheffer, Margaret M. Redfield, 
Kazuhlro Yamamoto, Chi-Ming Wei, John C. Bumeit Jr.. Cardiorenal 
Research, Mayo Clinic, Roohester' MN 
Since the isOlation of adrenomedullin (ADM) from human pheochmmocy- 
toma, accumulating evidence has eluddated that ADM is a novel vesore- 
laxing and natriuretic peptide that may play an important role in cardiorenai 
regulation. Recently, we have reported that plasma conce,~ation of ADM 
is increased in patients with severe congestive heart failure (CHF) and that 
increased irnmunahistochemical staining w~ts observed in the falling verdric- 
ular myoc, ardium. The present study was designed to examine the plasma 
concentration of ADM in association with parameters of cardiovascular hemo- 
dynamics in c l '~ l  stages of human CHF and to test the hypothesis that he 
failing human ventricle secretes ADM thus contributing to plasma concentra- 
tions. Plasma concentration of ADM was measured in 34 patients with CHF 
(20 men and 14 women; mean age. 64,6 years old) and 9 normal subjects 
(3 men and 6 women; 55,6 years ok;, using a specific redioimmunoassey 
for ADM. Plasma ADM concentration was significantly increased in patients 
with CHF ('34.6 :E 3.0 pg/mt, p < 0,01 vs. normal) as compared with normal 
subjects (14.4 d: 2.7 pg/ml). Plasma concenlretion of ADM was increased 
in mild (NYHA clas~ if) and moderate CHF (NYHA dase III) as well as in 
severe CHF (NYHA class IV). There was a weak negative correlation be- 
tween plasma concentration of ADM and left ventricular ejection fraction (r 
= 0.39, p < 0.05). In 13 patients with CHF in whom plasma samples were 
obtained from aorta and anterior interventricular vein (AIV) which receives 
blood exclusively from the left ventricle, them was a significant step-up in 
plasma concentration of ADM between aorta (47.7 :E 9.6 pg/mt) and AIV 
(57,4 =i: 10,2 pg/ml, p < 0.01 vs. aorta), This study demonstrates that plasma 
concentration of ADM is increased in patients with mild as well as moderate 
and severe CHF, and suggests that failing ventricles contribute to the release 
of ADM in patients with CHF. 
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4:00 
Stabil ity o f  Exercise Tolerance Test in Spite of  
.......... Coronary  Artery Disease Progression in Stable 
Angina 
Dimitris Tousoulis, Tom Crake ~, Graham Davies, Attilio Mased 2 Cardiology 
Units, Hammersmith Hospital, London: ~ St Bartholomew's Hospital, 
London; ~ Universita Caltolice, Rome 
We examined the relationship between changes in the exercise tolerance 
test and coronary artery dtseass progression in 27 patients with angina who 
remained clinically stable. They underwent repeat coronary angidgraphy 
after a inlenml of 27.3 :E 2.6 months. Stenosie severity was measured on 
the first and second angiograms using a computerized system. Although 
symptoms were unchanged in all, stenosis progression was observed in 11 
patients (group t) and not in 16 patients (group 2). In all patients the results 
Table I
Group I Group 2 
Rrst Second First Second 
angiogmm ...angl0gram anglogram angtogram 
Exerclse dumtlon (rain) 11.9:E 2.2 10.3±2.4 11.8±2.6 11.2±3.0 
~T depression at peak  1.13-;-0.5 1.4±0.4 1.32±0.5 1.31:E0.5 
exercise (ram) 
HR at peak 139±15 136:~18 140±13 t38:E 12 
exerdse (~m) 
Exerclse duration te 9.26± 2.1 8.15±2.3 9.5±2.5 9.1 ~:22 
1 mm ST SO (rain) 
HR at I I~rn ST segmewl 131:E12 133~14 134±72 130~11 
depression (bpm) 
8P- HR product al 204±26 193 :i: ~9 210=t:28 201:E21 
1 mm ST SD (mmHg.l~0m!__ 
bpm = beats per minute. HR = heart rate. BP = bleed pressure. 
of trP~zdmill exercise testing (modified Bruce protocol) in the month preceding 
the !iret angiegram was compared to that in the month precedir~- I the second 
ang=ogram. Exercise te~.ts were terminated by progressive angina or fatigue 
or when 2 mm ST segment depression had developed. Heart rate (HR) and 
heart rate-systolic blood pressure (HR-BP product) were recorded al 1 mm 
ST segment depression (SD) and at peak exercise in patients with positive 
exercise lasts; in patients with negative exercise tests heart rate and rate- 
pressure prnduct were recorded al peak exercise. The results (ms_an :E SEM) 
are shown in Table 1: 
In conclusion in patients with chronic stable angina Coronary stermses may 
progress without a signfficanl reduction of exercise duration, heart rate and 
rate-pressure product at 1 mm ST depression and at peak exercise. 
4 :15 
~ I s  ,Calcium a Sensit ive Marker  for  Coronary 
Atheroselerosis? An Intmvascular Ultrasound Study 
o f  1548 Native Arteries 
Gary S. Mintz, Augusto D. Pichard, Jeffrey J, Popma, Lowell F. Sailer, 
Kenneth M. Kent, Rainer Hoffman, Jennifer Gdffin, David Kautman, 
Susan Yeu~g, J. Hope Pacera, Chester Clark, Marlin B. Leon. Washington 
Hospital Center, Washington, DC 
The detection of coronary after- calcification (Ca) ~ninvaaively is used tO 
screen patients for coronary atherosclerosis, To validate this approach, we 
used intmvascular ultrasound (IVUS) and quentifative angingraphy (mea- 
surement of lesion d~w~,ter stenosis) to study target lesion and referenc~ 
(Ref) Segment Ca in 1548 native vessels. 
Angiographic _< 25% 26-50% 51-75% 76--100% p 
di',meter stenosis 
P,'US Ca (%) (59) (72) (78) (83) 0.0033 
L~ siorl ~rc of Ca '~ 60±78 t02±108 121:E 110 118±109 0.0002 
Ref amolCa Q 24..E 47 28±59 43±81 42±84 0.036 
However, when Ca was co , red  to the IVUS measured plaque burden 
(plaque area/total arterial area}, the prevalence of Ca did not reach 70% until 
the IVUS plaque burden exceeded 75%: 
[vus plaque burden < 50% 51-75% 76-es% S1-1QO% p 
1VUS Ca (%) (2~) (40) GO) (73) < 0.0001 
An= of Ca Q 24--60 50±81 95±98 105±99 <0.0001 
We ¢onc/ude: The presence and magnitude of Ca parallels the IVUS 
plaque burden more closely than the angiographic dian~ter stenasia. Ca is 
present in 70=/0 of arteries with an angiographic diameter stenesis > 25°/= or 
art IVUS plaque burden > 75%, but in only 40% with a plaque burden 50-  
75%. Therefore, coronmy artery Ca is useful for identifying hemodynamically 
significant disease, but is relatively insensitive for detecting "subc!iniCaT" 
coronary atheroselerosie (large plaque burden in the absence of lumin'.~l 
compromise). 
4:.30 
~ ' ~  Coronary Artery Calcif ication Sc~ening to Rule Out 
Acute Myoca~iial  Infarct ion Prior to Hospital 
Admission 
Tamas Balogh, Julia Hoif, Stuart Rich, Christopher J, Wotlklal. Univendty of 
Illinois at Chic~o, Chicago, IL 
Background: it is common practice to hospitalize pts presenting to the Emer- 
gency Room (ER) with chest pain (CP) incteding those without fxev~us 
history of coronary artery disease (CAD) or objective findings of m.tKcardtal 
tschemis. Electron beam tomography (EBT) can etiictently ider~ coronary 
artery calcium (CAC), which has been shown to be exclusively associated 
with coronary ather0sclereSis. The absence of CAC may be useful in identi- 
fying pts presenting to the ER with non-cardiac CP. 
Methods: Patients admitted from the ER with CP and without history of 
CAD, cocaine abuse or diagnostic ECG changes (5 74% of CP ndmiesions) 
were scanned for CAC. CAC screening was done within 7 days of admission. 
Positive CAC was defined as CAC scores >_ 1. Patients were ~,~0nitorad for 
coronary events (MI, unstable angina, PTCA or CABG) during hOst0italization 
and 30 days following discharge. 
Resulis: 133 pts, ages 53,1 :E 12.1 yra, (63% female) were s'c~lied. No pts 
were lost to follOw up after hospital discharge. Seven of 86 (8.1%) positive 
CAC pts had coronary events (4 MI, 1 PTCA, 2 CABG) during the follow 
up period. No patient without CAC (n = 47) developed an e~nt during the 
follow-up period. CAC was associated with events (Fisher's exact test p = 
o.o51) 
Conclusion: Utilization of EBT to detect CAC has the potential to identify 
pts presenting to the ER with CP with very low risk for comnsry events. CAC 
